resveratrol has been researched along with diallyl disulfide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alston-Mills, B; Bottone, FG; Eling, TE; Ishibashi, M; Kim, JS; Moon, Y | 1 |
Bei, R; Benvenuto, M; Fantini, M; Focaccetti, C; Galvano, F; Izzi, V; Lista, F; Marzocchella, L; Masuelli, L; Modesti, A; Palumbo, C; Tarantino, U; Tresoldi, I | 1 |
2 other study(ies) available for resveratrol and diallyl disulfide
Article | Year |
---|---|
The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3).
Topics: Activating Transcription Factor 3; Allyl Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Chromans; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Disulfides; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Male; Mice; Mice, Nude; Microarray Analysis; Neoplasm Invasiveness; Resveratrol; RNA, Messenger; Stilbenes; Sulindac; Thiazolidinediones; Transcription Factors; Transplantation, Heterologous; Troglitazone; Up-Regulation | 2005 |
Resveratrol and diallyl disulfide enhance curcumin-induced sarcoma cell apoptosis.
Topics: Allyl Compounds; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Curcumin; Disulfides; Drug Synergism; Humans; Resveratrol; Sarcoma; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53 | 2012 |